Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,General Medicine
Link
http://www.nature.com/articles/ncponc0168.pdf
Reference5 articles.
1. Miyamoto H and Messing EM (2004) Early versus late hormonal therapy for prostate cancer. Curr Urol Rep 5: 188–196
2. Merrick GS et al. (2005) Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 61: 32–43
3. Sandler HM (2004) Optimizing hormone therapy in localized prostate cancer: focus on external beam radiotherapy. J Urol 172 (Pt 2): S38–S41
4. D'Amico AV et al. (2004) 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 292: 821–827
5. Messing EM et al. (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341: 1781–1788
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer;Journal of Translational Medicine;2024-01-14
2. Integrating Single-cell and Bulk RNA Sequencing Data Unveils Antigen Presentation and Process-related CAFs and Establishes a Predictive Signature in Prostate Cancer;2023-08-10
3. Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer;Cell Death Discovery;2023-03-06
4. A hybrid spatiotemporal model of PCa dynamics and insights into optimal therapeutic strategies;Mathematical Biosciences;2023-01
5. Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer;Cancer Gene Therapy;2021-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3